Peroxisome proliferator-activated receptor-alpha activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade
about
Role of 20-hydroxyeicosatetraenoic acid in mediating hypertension in response to chronic renal medullary endothelin type B receptor blockadePeroxisome proliferator-activated receptors for hypertension.Contrasting effects of intervention with ETA and ETB receptor antagonists in hypertension induced by angiotensin II and high-salt dietRole of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mousePeroxisome Proliferator-Activated Receptor-α Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension.Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused MiceColfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension.Endothelin, kidney disease, and hypertension.PPARα-dependent increase of mouse urine output by gemfibrozil and fenofibrate.PPARα ligand clofibrate ameliorates blood pressure and vascular reactivity in spontaneously hypertensive rats.Regulation of blood pressure, natriuresis and renal thiazide/amiloride sensitivity in PPARalpha null mice.PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats.
P2860
Q34053475-98551FF5-E191-40E7-831C-417319D398D7Q34179017-7377F043-705B-4BA3-8FDA-174C6E4054C1Q34630324-009A38EB-BE22-489C-A7A1-4009D2499880Q35135229-C1D04FA6-D905-4071-8247-E2D8EB34863EQ35498269-A2A3109E-94EE-45FD-9485-890C5912A653Q35608633-ED1AABE4-6FF5-492D-A2E3-29BBFEBD16E2Q36119361-F43C9F92-D867-4792-AF87-B577D566DA79Q36982658-F2ECAB57-B699-42DC-8DC2-3B6EE72B4BBCQ37244292-A8F24A52-0824-4561-ACDF-3A93B19A3E43Q39130668-A1E4ECD6-7D54-4691-A6B4-13B1F83BBC6CQ39683151-9640F64B-BF12-4751-8AE1-CC3A3A26644CQ44239626-3291CE39-6032-4D5F-AF26-88D1AFD51C11Q46752310-00A7DB68-B92A-42E1-BEF0-697178349B50
P2860
Peroxisome proliferator-activated receptor-alpha activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade
description
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Juni 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/08/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/08/01)
@nl
наукова стаття, опублікована в серпні 2005
@uk
مقالة علمية (نشرت في أغسطس 2005)
@ar
name
Peroxisome proliferator-activa ...... endothelin B receptor blockade
@ast
Peroxisome proliferator-activa ...... endothelin B receptor blockade
@en
Peroxisome proliferator-activa ...... endothelin B receptor blockade
@nl
type
label
Peroxisome proliferator-activa ...... endothelin B receptor blockade
@ast
Peroxisome proliferator-activa ...... endothelin B receptor blockade
@en
Peroxisome proliferator-activa ...... endothelin B receptor blockade
@nl
prefLabel
Peroxisome proliferator-activa ...... endothelin B receptor blockade
@ast
Peroxisome proliferator-activa ...... endothelin B receptor blockade
@en
Peroxisome proliferator-activa ...... endothelin B receptor blockade
@nl
P2093
P1433
P1476
Peroxisome proliferator-activa ...... endothelin B receptor blockade
@en
P2093
David M Pollock
Jan Michael Williams
Mong H Wang
Xueying Zhao
P304
P356
10.1161/01.HYP.0000172755.25382.FC
P407
P50
P577
2005-06-20T00:00:00Z